SARS-CoV-2 Mpro-IN-8
SARS-CoV-2 Mpro-IN-8 (compound 6b) is an antiviral agent with anti-SARS-CoV-2 properties[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-mpro-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C1[C@@]2([C@]3(C(C=C(Cl)C=C4)=C4NC3=O)N(C)C[C@]2(C5=CC=CC=C5)[H])CN(P(OCC)(OCC)=O)C/C1=C\C6=CC=CC=C6
Molecular Formula
C33H35ClN3O5P
Molecular Weight
620.07
References & Citations
[1]Bekheit MS, et al. Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties. Eur J Med Chem. 2023 Oct 5;258:115563.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1407589-01 0.02 mg (E-Coli)
Recombinant Lotus japonicus NAD (P)H-quinone oxidoreductase subunit I, chloroplastic (ndhI)
Ask
View Details 
MBS1407589-02 0.1 mg (E-Coli)
Recombinant Lotus japonicus NAD (P)H-quinone oxidoreductase subunit I, chloroplastic (ndhI)
Ask
View Details MBS1407589-03 0.02 mg (Yeast)
Recombinant Lotus japonicus NAD (P)H-quinone oxidoreductase subunit I, chloroplastic (ndhI)
Ask
View Details 
MBS1407589-04 0.1 mg (Yeast)
Recombinant Lotus japonicus NAD (P)H-quinone oxidoreductase subunit I, chloroplastic (ndhI)
Ask
View Details MBS1407589-05 0.02 mg (Baculovirus)
Recombinant Lotus japonicus NAD (P)H-quinone oxidoreductase subunit I, chloroplastic (ndhI)
Ask
View Details